Predicted Structures for Kappa Opioid G-Protein Coupled Receptor Bound to Selective Agonists
暂无分享,去创建一个
Hongwei Tan | William A. Goddard | Guangju Chen | Quanjie Li | Soo-Kyung Kim | W. Goddard | H. Tan | Guangju Chen | Soo-Kyung Kim | Quanjie Li
[1] M. Congreve,et al. Structure of the adenosine A(2A) receptor in complex with ZM241385 and the xanthines XAC and caffeine. , 2011, Structure.
[2] R. Abagyan,et al. Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists , 2010, Science.
[3] T. Creamer,et al. Solvation energies of amino acid side chains and backbone in a family of host-guest pentapeptides. , 1996, Biochemistry.
[4] Xufeng Sun,et al. Syntheses and opioid receptor binding affinities of 8-amino-2,6-methano-3-benzazocines. , 2003, Journal of medicinal chemistry.
[5] Juanita Dortch-Carnes,et al. Bremazocine: a kappa-opioid agonist with potent analgesic and other pharmacologic properties. , 2005, CNS drug reviews.
[6] Michael Berlin,et al. Histamine H3 receptor as a drug discovery target. , 2011, Journal of medicinal chemistry.
[7] G. Pasternak,et al. An opiate-receptor gene family reunion , 1994, Trends in Neurosciences.
[8] W. Goddard,et al. Structure prediction of G protein-coupled receptors and their ensemble of functionally important conformations. , 2012, Methods in molecular biology.
[9] B. Bloch,et al. kappa-Opioid receptor in humans: cDNA and genomic cloning, chromosomal assignment, functional expression, pharmacology, and expression pattern in the central nervous system. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[10] R. N. Brogden,et al. Pentazocine: A Review of its Pharmacological Properties, Therapeutic Efficacy and Dependence Liability , 2012, Drugs.
[11] W. Goddard,et al. Conformational ensemble view of G protein-coupled receptors and the effect of mutations and ligand binding. , 2013, Methods in enzymology.
[12] N. Yamaotsu,et al. 3D-Pharmacophore Identification for κ-Opioid Agonists Using Ligand-Based Drug-Design Techniques , 2010 .
[13] H. Emrich,et al. Psychotomimesis mediated by kappa opiate receptors , 1986, Science.
[14] W. Goddard,et al. Use of G-Protein-Coupled and -Uncoupled CCR5 Receptors by CCR5 Inhibitor-Resistant and -Sensitive Human Immunodeficiency Virus Type 1 Variants , 2013, Journal of Virology.
[15] Yoshinori Shichida,et al. Functional role of internal water molecules in rhodopsin revealed by x-ray crystallography , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[16] Patrick Scheerer,et al. Crystal structure of the ligand-free G-protein-coupled receptor opsin , 2008, Nature.
[17] Tsutomu Kouyama,et al. Crystal structure of squid rhodopsin , 2008, Nature.
[18] Gebhard F. X. Schertler,et al. Structure of a β1-adrenergic G-protein-coupled receptor , 2008, Nature.
[19] Manfred Burghammer,et al. Structure of bovine rhodopsin in a trigonal crystal form. , 2003, Journal of molecular biology.
[20] K. Palczewski,et al. Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.
[21] R. Stevens,et al. Structure of an Agonist-Bound Human A2A Adenosine Receptor , 2011, Science.
[22] Manfred Burghammer,et al. Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. , 2007, Nature.
[23] Brian K. Kobilka,et al. High resolution crystal structure of human B2-adrenergic G protein-coupled receptor. , 2007 .
[24] S. Rasmussen,et al. Crystal Structure of the β2Adrenergic Receptor-Gs protein complex , 2011, Nature.
[25] Xavier Deupi,et al. Structural insights into agonist-induced activation of G-protein-coupled receptors. , 2011, Current opinion in structural biology.
[26] Jonathan A. Javitch,et al. Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist , 2010, Science.
[27] Jun Tan,et al. 3D Structure Prediction of TAS2R38 Bitter Receptors Bound to Agonists Phenylthiocarbamide (PTC) and 6-n-Propylthiouracil (PROP) , 2012, J. Chem. Inf. Model..
[28] William A. Goddard,et al. SuperBiHelix method for predicting the pleiotropic ensemble of G-protein–coupled receptor conformations , 2013, Proceedings of the National Academy of Sciences.
[29] R. Stevens,et al. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. , 2007, Science.
[30] Caitlin E. Scott,et al. Molecular basis for dramatic changes in cannabinoid CB1 G protein‐coupled receptor activation upon single and double point mutations , 2013, Protein science : a publication of the Protein Society.
[31] A. Leslie,et al. Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation , 2011, Nature.
[32] Jiyoung Heo,et al. Predicted structure of agonist-bound glucagon-like peptide 1 receptor, a class B G protein-coupled receptor , 2012, Proceedings of the National Academy of Sciences.
[33] William A. Goddard,et al. How broadly tuned olfactory receptors equally recognize their agonists. Human OR1G1 as a test case , 2012, Cellular and Molecular Life Sciences.
[34] J. M. Kennedy,et al. Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications. , 1998, NIDA research monograph.
[35] W. Goddard,et al. Characterizing and predicting the functional and conformational diversity of seven-transmembrane proteins. , 2011, Methods.
[36] J. Thompson,et al. The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. , 1976, The Journal of pharmacology and experimental therapeutics.
[37] K. Garcia,et al. Different thermodynamic binding mechanisms and peptide fine specificities associated with a panel of structurally similar high-affinity T cell receptors. , 2008, Biochemistry.
[38] S. Rasmussen,et al. Structure of a nanobody-stabilized active state of the β2 adrenoceptor , 2010, Nature.
[39] P. Glare,et al. Clinical pharmacokinetics of morphine. , 1991, Therapeutic drug monitoring.
[40] Juanita Dortch-Carnes,et al. Bremazocine: A κ-Opioid Agonist with Potent Analgesic and Other Pharmacologic Properties , 2006 .
[41] M. Waldhoer,et al. Opioid receptors. , 2004, Annual review of biochemistry.
[42] Aashish Manglik,et al. Structure of the δ-opioid receptor bound to naltrindole , 2012, Nature.
[43] C. Chavkin,et al. Dynorphin is a specific endogenous ligand of the kappa opioid receptor. , 1982, Science.
[44] Nagarajan Vaidehi,et al. Ligand-stabilized conformational states of human beta(2) adrenergic receptor: insight into G-protein-coupled receptor activation. , 2008, Biophysical journal.
[45] Ravinder Abrol,et al. Bihelix: Towards de novo structure prediction of an ensemble of G‐protein coupled receptor conformations , 2012, Proteins.
[46] G. Pasternak,et al. Pharmacological characterization of nalorphine, a kappa 3 analgesic. , 1991, The Journal of pharmacology and experimental therapeutics.
[47] Arthur Christopoulos,et al. Functional Selectivity and Classical Concepts of Quantitative Pharmacology , 2007, Journal of Pharmacology and Experimental Therapeutics.
[48] Vadim Cherezov,et al. A specific cholesterol binding site is established by the 2.8 A structure of the human beta2-adrenergic receptor. , 2008, Structure.
[49] Gebhard F. X. Schertler,et al. The structural basis of agonist-induced activation in constitutively active rhodopsin , 2011, Nature.
[50] Tetsuya Hori,et al. Crystal Structure of Squid Rhodopsin with Intracellularly Extended Cytoplasmic Region , 2008, Journal of Biological Chemistry.
[51] Stephen Taylor,et al. Molecular dynamics for very large systems on massively parallel computers: The MPSim program , 1997, J. Comput. Chem..
[52] S. Joel,et al. Morphine and metabolite behavior after different routes of morphine administration: Demonstration of the importance of the active metabolite morphine‐6‐glucuronide , 1990, Clinical pharmacology and therapeutics.
[53] Bartosz Trzaskowski,et al. Ligand- and mutation-induced conformational selection in the CCR5 chemokine G protein-coupled receptor , 2014, Proceedings of the National Academy of Sciences.
[54] Bryan L. Roth,et al. Structure of the Nociceptin/Orphanin FQ Receptor in Complex with a Peptide Mimetic , 2012, Nature.
[55] 宁北芳,et al. 疟原虫var基因转换速率变化导致抗原变异[英]/Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .
[56] William L. Jorgensen,et al. Journal of Chemical Information and Modeling , 2005, J. Chem. Inf. Model..
[57] P B Bradley,et al. International Union of Pharmacology. XII. Classification of opioid receptors. , 1996, Pharmacological reviews.
[58] Structure. Rhodopsin sees the light. , 2000, Science.
[59] M. Burghammer,et al. Crystal structure of the human β2 adrenergic G-protein-coupled receptor , 2007, Nature.
[60] E. Meng,et al. Rhodopsin Sees the Light , 2000, Science.
[61] Sharon Brunett,et al. Molecular dynamics for very large systems on massively parallel computers: The MPSim program , 1997 .
[62] K. Williams,et al. Importance of Drug Enantiomers in Clinical Pharmacology , 1985, Drugs.
[63] R. Stevens,et al. Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions , 2012, Science.
[64] Vadim Cherezov,et al. Allosteric sodium in class A GPCR signaling. , 2014, Trends in biochemical sciences.
[65] W. Goddard,et al. Predicted structures of agonist and antagonist bound complexes of adenosine A3 receptor , 2011, Proteins.
[66] E Novellino,et al. Modeling of kappa-opioid receptor/agonists interactions using pharmacophore-based and docking simulations. , 2000, Journal of medicinal chemistry.
[67] H. Kosterlitz,et al. Bremazocine is an agonist at K‐opioid receptors and an antagonist at μ‐opioid receptors in the guinea‐pig myenteric plexus , 1986, British journal of pharmacology.
[68] Nagarajan Vaidehi,et al. The role of conformational ensembles in ligand recognition in G-protein coupled receptors. , 2011, Journal of the American Chemical Society.
[69] Marcus Elstner,et al. The retinal conformation and its environment in rhodopsin in light of a new 2.2 A crystal structure. , 2004, Journal of molecular biology.
[70] T. Kenakin,et al. The role of conformational ensembles of seven transmembrane receptors in functional selectivity. , 2010, Current opinion in pharmacology.
[71] A. Keats,et al. Nalorphine, a potent analgesic in man. , 1956, The Journal of pharmacology and experimental therapeutics.
[72] Cheng Zhang,et al. Structure and Function of an Irreversible Agonist-β2 Adrenoceptor complex , 2010, Nature.
[73] L. Pasquinucci,et al. Non-peptide ligands for opioid receptors. Design of kappa-specific agonists. , 1993, Journal of medicinal chemistry.
[74] Xavier Deupi,et al. The effect of ligand efficacy on the formation and stability of a GPCR-G protein complex , 2009, Proceedings of the National Academy of Sciences.
[75] W. Goddard,et al. Flat-Bottom Strategy for Improved Accuracy in Protein Side-Chain Placements. , 2008, Journal of chemical theory and computation.
[76] G. Pasternak. Multiple opiate receptors: [3H]ethylketocyclazocine receptor binding and ketocyclazocine analgesia. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[77] Caitlin E. Scott,et al. Computationally‐predicted CB1 cannabinoid receptor mutants show distinct patterns of salt‐bridges that correlate with their level of constitutive activity reflected in G protein coupling levels, thermal stability, and ligand binding , 2013, Proteins.
[78] G. Uhl,et al. -mu opiate receptor. Charged transmembrane domain amino acids are critical for agonist recognition and intrinsic activity. , 1994, The Journal of biological chemistry.
[79] R. Stevens,et al. High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor , 2007, Science.
[80] R. Nussinov,et al. The role of dynamic conformational ensembles in biomolecular recognition. , 2009, Nature chemical biology.
[81] Jerzy Ciarkowski,et al. Molecular dynamics study of the internal water molecules in vasopressin and oxytocin receptors. , 2009, Protein and peptide letters.
[82] Bryan L. Roth,et al. Structure of the human kappa opioid receptor in complex with JDTic , 2012, Nature.
[83] Oliver P. Ernst,et al. Crystal structure of metarhodopsin II , 2011, Nature.
[84] Oliver P. Ernst,et al. Crystal structure of opsin in its G-protein-interacting conformation , 2008, Nature.
[85] Todd J. A. Ewing,et al. DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases , 2001, J. Comput. Aided Mol. Des..
[86] L. Pardo,et al. Crystal structure of the μ-opioid receptor bound to a morphinan antagonist , 2012, Nature.
[87] S. L. Mayo,et al. DREIDING: A generic force field for molecular simulations , 1990 .
[88] Cécile Béguin,et al. Kappa-opioid ligands in the study and treatment of mood disorders. , 2009, Pharmacology & therapeutics.